Predict your next investment

Corporation
HEALTHCARE | Drug Development
hyperiontx.com

See what CB Insights has to offer

Competitors

14

Business Relationships

1

Service Providers

6

Hyperion Therapeutics Competitors & Alternatives

14 Competitors

Hyperion Therapeutics has 14 competitors. Hyperion Therapeutics's competitors are CoImmune, Acorda Therapeutics, Annovis Bio, Aegerion Pharmaceuticals, BioCardia and more.

Latest Funding

Companies

Investment Stage

Total Funding

Mosaic
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

Location

11/10/2020

Unattributed VC

$240.07M

North Carolina

4/27/2020

Loan

$144.54M

New York

1/29/2020

IPO

$11.88M

Pennsylvania

5/21/2019

Asset Sale

$40.11M

Massachusetts

8/23/2016

Reverse Merger

California

3/18/2016

CoMentis

Series E

$82.19M

California

6/6/2014

Radius Health

IPO

$224.5M

Massachusetts

4/29/2014

iPierian

Acquired

$95.67M

California

5/1/2013

NeuroTherapeutics Pharma

Dead

$60.7M

Illinois

8/17/2012

Elevation Pharmaceuticals

Acquired

$60.24M

California

Latest Funding

11/10/2020

4/27/2020

1/29/2020

5/21/2019

8/23/2016

3/18/2016

6/6/2014

4/29/2014

5/1/2013

8/17/2012

Companies

CoMentis

Radius Health

iPierian

NeuroTherapeutics Pharma

Elevation Pharmaceuticals

Investment Stage

Unattributed VC

Loan

IPO

Asset Sale

Reverse Merger

Series E

IPO

Acquired

Dead

Acquired

Total Funding

$240.07M

$144.54M

$11.88M

$40.11M

$82.19M

$224.5M

$95.67M

$60.7M

$60.24M

Mosaic

Location

North Carolina

New York

Pennsylvania

Massachusetts

California

California

Massachusetts

California

Illinois

California

Hyperion Therapeutics Service Providers

6 Service Providers

Hyperion Therapeutics has 6 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

IPO

Counsel

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

Subscribe to see more

Subscribe to see more

Associated Rounds

IPO

Subscribe to see more

Subscribe to see more

Provider Type

Counsel

Subscribe to see more

Subscribe to see more

Service Type

Subscribe to see more

Subscribe to see more

Partnership data by VentureSource

Hyperion Therapeutics Partners & Customers

1 Partners and customers

Hyperion Therapeutics has 1 strategic partners and customers. Hyperion Therapeutics recently partnered with Clal Biotechnology Industries on October 10, 2014.

Date

Type

Business Partner

Country

News Snippet

Sources

10/7/2014

Partner

Clal Biotechnology Industries

Israel

Hyperion Therapeutics and Clal Biotechnology Industries Ltd. Enter Into Interim Agreement

BRISBANE , Calif. and RAMAT GAN , Israel , Oct. 7 , 2014 -- Hyperion Therapeutics , Inc. and Clal Biotechnology Industries Ltd. today announced that they have entered into an interim agreement in order to attempt to resolve the disputes between them and to allow CBI to evaluate whether there is any clinical efficacy to , and whether there is a potential regulatory path forward for , DiaPep277 that a party other than Hyperion Therapeutics , Inc. may wish to pursue .

1

Date

10/7/2014

Type

Partner

Business Partner

Clal Biotechnology Industries

Country

Israel

News Snippet

Hyperion Therapeutics and Clal Biotechnology Industries Ltd. Enter Into Interim Agreement

BRISBANE , Calif. and RAMAT GAN , Israel , Oct. 7 , 2014 -- Hyperion Therapeutics , Inc. and Clal Biotechnology Industries Ltd. today announced that they have entered into an interim agreement in order to attempt to resolve the disputes between them and to allow CBI to evaluate whether there is any clinical efficacy to , and whether there is a potential regulatory path forward for , DiaPep277 that a party other than Hyperion Therapeutics , Inc. may wish to pursue .

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.